Dr. Reddy’s updates investor meetings schedule
Dr. Reddy’s Laboratories Limited has notified exchanges that its management will participate in an investor conference organized by Kotak Institutional Equities.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Dr. Reddy’s Laboratories Limited has notified exchanges that its management will participate in an investor conference organized by Kotak Institutional Equities. The meetings are scheduled in Mumbai on 23 February 2026, will be held in person, and structured as group meets from 09:00 to 17:00 IST. The company notes the schedule may change if required by either the investors or the company.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does Dr. Reddy’s Laboratories (RDY) announce in this Form 6-K?
When are Dr. Reddy’s (RDY) analyst and institutional investor meetings scheduled?
Where will Dr. Reddy’s (RDY) investor conference meetings take place?
What is the nature and mode of Dr. Reddy’s (RDY) investor meetings?
Can the schedule of Dr. Reddy’s (RDY) investor meetings change?
AI-generated analysis. How Rhea-AI works. Not financial advice.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
February, 2026
Commission File Number 1-15182
DR. REDDY’S LABORATORIES LIMITED
(Translation of registrant’s name into English)
8-2-337, Road No. 3, Banjara Hills
Hyderabad, Telangana 500 034, India
+91-40-49002900
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F x Form 40-F ¨
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ______
Note: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ______
Note: Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant’s “home country”), or under the rules of the home country exchange on which the registrant’s securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant’s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.
Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes ¨ No x
If “Yes” is marked, indicate below the file number assigned to registrant in connection with Rule 12g3-2(b): 82-________.
EXHIBITS
Exhibit Number |
| Description of Exhibits |
|
|
|
99.1 | Intimation dated February 12, 2026 |
| 2 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| DR. REDDY’S LABORATORIES LIMITED (Registrant) | ||
|
|
| |
Date: February 12, 2026 | By: | /s/ K Randhir Singh | |
|
| Name: | K Randhir Singh |
|
| Title: | Company Secretary |
| 3 |
Exhibit 99.1
 | Dr. Reddy's Laboratories Ltd. |
8-2-337, Road No. 3, Banjara Hills | |
Hyderabad – 500 034, Telangana, India | |
| |
CIN: L85195TG1984PLC004507 | |
| |
Tel: + 91 40 4900 2900 | |
Fax: + 91 40 4900 2999 | |
Email: mail@drreddys.com | |
Web: www.drreddys.com |
February 12, 2026
National Stock Exchange of India Ltd. (Scrip Code: DRREDDY)
BSE Limited (Scrip Code: 500124)
New York Stock Exchange Inc. (Stock Code: RDY)
NSE IFSC Ltd. (Stock Code: DRREDDY)
Dear Sir/Madam,
Sub: Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Schedule of Analyst / Institutional Investor Meetings
This is to inform that the Company’s management will be participating in the following investor conference with single institution(s)/ investor groups:
Date | Organized by | Location | Meeting mode | Nature of meet | Timing |
23.02.2026 | Kotak Institutional Equities | Mumbai | In – Person | Group Meet | 09:00 - 17:00 IST |
Please note that the schedule of the aforesaid meeting is subject to change due to any exigencies on the part of Investors / Company.
This is for your information.
Thanking you.
Yours faithfully,
For Dr. Reddy’s Laboratories Limited
K Randhir Singh
Company Secretary, Compliance Officer & Head-CSR